Wang LR - Search Results

1

First-line gemcitabine plus cisplatin in nonsmall cell lung cancer patients.

Li Y, Wang LR, Chen J, Lou Y, Zhang GB. Li Y, et al. Among authors: wang lr. Dis Markers. 2014;2014:960458. doi: 10.1155/2014/960458. Epub 2014 Jan 23. Dis Markers. 2014. PMID: 24591771 Free PMC article. Clinical Trial.

2

Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer.

Wang LR, Huang MZ, Xu N, Shentu JZ, Liu J, Cai J. Wang LR, et al. J Zhejiang Univ Sci B. 2005 May;6(5):446-50. doi: 10.1631/jzus.2005.B0446. J Zhejiang Univ Sci B. 2005. PMID: 15822162 Free PMC article. Clinical Trial.

3

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer.

Wang L, Wu X, Huang M, Cai J, Xu N, Liu J. Wang L, et al. Cancer Chemother Pharmacol. 2007 Jul;60(2):211-8. doi: 10.1007/s00280-006-0363-x. Epub 2006 Nov 24. Cancer Chemother Pharmacol. 2007. PMID: 17124596 Clinical Trial.

4

Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer.

Wang LR, Liu J, Huang MZ, Xu N. Wang LR, et al. J Zhejiang Univ Sci B. 2007 May;8(5):307-13. doi: 10.1631/jzus.2007.B0307. J Zhejiang Univ Sci B. 2007. PMID: 17542057 Free PMC article. Clinical Trial.

5

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

Wang LR, Huang MZ, Zhang GB, Xu N, Wu XH. Wang LR, et al. Cancer Chemother Pharmacol. 2007 Sep;60(4):601-7. doi: 10.1007/s00280-007-0504-x. Epub 2007 Jun 5. Cancer Chemother Pharmacol. 2007. PMID: 17549479 Clinical Trial.

6

[Peak concentration of gemcitabine at fixed-dose-rate and its hematological toxicity profile].

Wang LR, Zhang GB, Huang MZ. Wang LR, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jul;36(4):391-5. doi: 10.3785/j.issn.1008-9292.2007.04.015. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17717833 Chinese.

7

[Detection of RRM1, ERCC1 and BRCA1 gene expression in non-small cell lung cancer tissues and peripheral blood by SYBR real-time fluorescent quantitative PCR].

Chen J, Li MW, Zhang GB, Li J, Wang LR. Chen J, et al. Among authors: wang lr. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Nov;39(6):628-33. doi: 10.3785/j.issn.1008-9292.2010.06.013. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21166058 Chinese.

8

RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum.

Wang LR, Zhang GB, Chen J, Li J, Li MW, Xu N, Wang Y, Shen Tu JZ. Wang LR, et al. Among authors: wang y. J Zhejiang Univ Sci B. 2011 Mar;12(3):174-9. doi: 10.1631/jzus.B1000197. J Zhejiang Univ Sci B. 2011. PMID: 21370501 Free PMC article.

9

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.

Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Wang Y, Shentu JZ. Zhang GB, et al. Among authors: wang y, wang lr. Cancer Chemother Pharmacol. 2012 May;69(5):1277-87. doi: 10.1007/s00280-012-1834-x. Cancer Chemother Pharmacol. 2012. PMID: 22302408 Clinical Trial.

10

[Expression of RRM1 and ERCC1 genes in tumor tissues and peripheral blood lymphocytes of advanced non-small cell lung cancer].

Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Shen-Tu JZ. Zhang GB, et al. Among authors: wang lr. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Sep;41(5):540-6. doi: 10.3785/j.issn.1008-9292.2012.05.012. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23086647 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters